JP2020522566A5 - - Google Patents

Download PDF

Info

Publication number
JP2020522566A5
JP2020522566A5 JP2020514147A JP2020514147A JP2020522566A5 JP 2020522566 A5 JP2020522566 A5 JP 2020522566A5 JP 2020514147 A JP2020514147 A JP 2020514147A JP 2020514147 A JP2020514147 A JP 2020514147A JP 2020522566 A5 JP2020522566 A5 JP 2020522566A5
Authority
JP
Japan
Prior art keywords
synthetic polynucleotide
composition
seq
synthetic
end cap
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020514147A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020522566A (ja
JP7317805B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/033376 external-priority patent/WO2018213697A1/en
Publication of JP2020522566A publication Critical patent/JP2020522566A/ja
Publication of JP2020522566A5 publication Critical patent/JP2020522566A5/ja
Priority to JP2023061093A priority Critical patent/JP7781815B2/ja
Application granted granted Critical
Publication of JP7317805B2 publication Critical patent/JP7317805B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020514147A 2017-05-19 2018-05-18 フォン・ヴィレブランド因子に関連する合併症及び障害の処置のための組成物及び方法 Active JP7317805B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023061093A JP7781815B2 (ja) 2017-05-19 2023-04-05 フォン・ヴィレブランド因子に関連する合併症及び障害の処置のための組成物及び方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762508530P 2017-05-19 2017-05-19
US62/508,530 2017-05-19
US201862638579P 2018-03-05 2018-03-05
US62/638,579 2018-03-05
PCT/US2018/033376 WO2018213697A1 (en) 2017-05-19 2018-05-18 Compositions and methods for the treatment of complications and disorders relating to von willebrand factor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023061093A Division JP7781815B2 (ja) 2017-05-19 2023-04-05 フォン・ヴィレブランド因子に関連する合併症及び障害の処置のための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2020522566A JP2020522566A (ja) 2020-07-30
JP2020522566A5 true JP2020522566A5 (https=) 2021-05-20
JP7317805B2 JP7317805B2 (ja) 2023-07-31

Family

ID=64274836

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020514147A Active JP7317805B2 (ja) 2017-05-19 2018-05-18 フォン・ヴィレブランド因子に関連する合併症及び障害の処置のための組成物及び方法
JP2023061093A Active JP7781815B2 (ja) 2017-05-19 2023-04-05 フォン・ヴィレブランド因子に関連する合併症及び障害の処置のための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023061093A Active JP7781815B2 (ja) 2017-05-19 2023-04-05 フォン・ヴィレブランド因子に関連する合併症及び障害の処置のための組成物及び方法

Country Status (11)

Country Link
US (3) US11060094B2 (https=)
EP (1) EP3624801A4 (https=)
JP (2) JP7317805B2 (https=)
KR (1) KR102830459B1 (https=)
CN (2) CN110520128B (https=)
AU (1) AU2018269935B2 (https=)
CA (1) CA3058001A1 (https=)
IL (1) IL269641B2 (https=)
MX (1) MX390865B (https=)
TW (1) TWI806868B (https=)
WO (1) WO2018213697A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021158583A1 (en) * 2020-02-04 2021-08-12 Band Therapeutics, Llc Regulation of von willebrand factor (vwf)
KR20220150303A (ko) * 2020-02-04 2022-11-10 다케다 야쿠힌 고교 가부시키가이샤 재조합 vwf의 투여에 의한 중증 폰 빌레브란트병 환자의 월경과다 치료
US20240002861A1 (en) * 2020-11-24 2024-01-04 Band Therapeutics, Llc Compositions and methods for treatment of bleeding disorders
CN116723863A (zh) * 2020-11-24 2023-09-08 邦德治疗有限公司 用于治疗出血性病症的组合物和方法
US12090243B2 (en) 2021-03-24 2024-09-17 Aleo Bme, Inc. Compositions comprising fluid gels for tissue separation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566701B2 (en) 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
KR20070101227A (ko) * 2004-09-07 2007-10-16 아케믹스 코포레이션 폰 빌레브란트 인자에 대한 앱타머 및 이의 혈전증치료제로서의 용도
US7563601B1 (en) * 2005-06-01 2009-07-21 City Of Hope Artificial riboswitch for controlling pre-mRNA splicing
US20110118187A1 (en) * 2006-10-19 2011-05-19 Duke University Reversible platelet inhibition
US20090203766A1 (en) * 2007-06-01 2009-08-13 Archemix Corp. vWF aptamer formulations and methods for use
WO2010091396A2 (en) * 2009-02-09 2010-08-12 Archemix Corp. Aptamers to von willerbrand factor and their use as thrombotic, hematologic and cardiovascular disease therapeutics
WO2015163458A1 (ja) * 2014-04-24 2015-10-29 株式会社リボミック オートタキシンに結合しオートタキシンの生理活性を阻害するアプタマー及びその利用
EP3266871B1 (en) * 2015-03-06 2021-04-28 TAGCyx Biotechnologies Inc. Method for stabilizing dna aptamers
KR102640903B1 (ko) 2015-10-30 2024-02-27 탁시스 바이오 가부시키가이샤 vWF에 결합하는 DNA 앱타머
WO2021158583A1 (en) * 2020-02-04 2021-08-12 Band Therapeutics, Llc Regulation of von willebrand factor (vwf)
US20240002861A1 (en) * 2020-11-24 2024-01-04 Band Therapeutics, Llc Compositions and methods for treatment of bleeding disorders
WO2023039522A1 (en) * 2021-09-10 2023-03-16 Guardian Therapeutics, Llc Fatty acid conjugates of nucleic acids

Similar Documents

Publication Publication Date Title
JP2020522566A5 (https=)
JP2018522563A5 (https=)
AU2017202919B2 (en) Pegylated Apelin and uses thereof
JP2014518612A5 (https=)
JPWO2021156267A5 (https=)
CA2984498C (en) Compositions and methods for inhibiting gene expression of hif2alpha
JP7291418B2 (ja) Ｐｃｓｋ９を標的としたアンチセンス核酸
JP2018515101A5 (https=)
KR20220024192A (ko) 변형된 갭머 올리고뉴클레오타이드 및 사용 방법
US10328182B2 (en) Compositions and methods for reducing neointima formation
JP2020526514A5 (https=)
JP2019524151A5 (https=)
HUE032125T2 (en) Preparation containing encapsulated antagomir
US20190071670A1 (en) Methods Of Treatment For Alpha-1 Antitrypsin Deficiency
EP1463518A2 (en) Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression
JP2020517632A5 (https=)
US7619066B2 (en) IL-1ra variants
JP2018521086A5 (https=)
WO2021030326A1 (en) Brush polymers for therapeutic applications
JPWO2021096763A5 (https=)
JP2020517646A5 (https=)
US9938533B2 (en) DNA aptamers specific to CD200R1 and their therapeutic uses
JP2021536461A5 (https=)
RU2202557C2 (ru) Производные циклопептидов
JP2020531480A5 (https=)